BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bessissow T, Nguyen GC, Tarabain O, Peyrin-Biroulet L, Foucault N, McHugh K, Ruel J. Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study. World J Gastroenterol 2022; 28(34): 5058-5075 [PMID: 36160646 DOI: 10.3748/wjg.v28.i34.5058]
URL: https://www.wjgnet.com/1007-9327/full/v28/i34/5058.htm
Number Citing Articles
AdalimumabReactions Weekly 2023; 1952(1): 28 doi: 10.1007/s40278-023-37121-1